Back to today’s briefing

Story perspectives

New Tool Predicts Bevacizumab Efficacy in Bowel Cancer Patients

4/13/2026

40 8 Full Breakdown

Summary

Story summary

Researchers from the Institute of Cancer Research in London and RCSI University of Medicine and Health Sciences developed PhenMap to predict bevacizumab responses in advanced bowel cancer.
PhenMap aims to spare patients unlikely to benefit from bevacizumab unnecessary treatment.
The study tracked 117 patients and identified those at risk of adverse reactions.
Results are promising but require validation in a larger group before broader UK use.

1 of 1

Story summary

Researchers from the Institute of Cancer Research in London and RCSI University of Medicine and Health Sciences developed PhenMap to predict bevacizumab responses in advanced bowel cancer.
PhenMap aims to spare patients unlikely to benefit from bevacizumab unnecessary treatment.
The study tracked 117 patients and identified those at risk of adverse reactions.
Results are promising but require validation in a larger group before broader UK use.